2022
DOI: 10.1016/j.jval.2022.04.1141
|View full text |Cite
|
Sign up to set email alerts
|

HTA7 Cost-Effectiveness Analysis of Nivolumab Plus Chemotherapy Vs Chemotherapy in Patients with Advanced Gastric Cancer in Japan

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles